The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review

N Fossati, PPM Willemse, T Van den Broeck… - European urology, 2017 - Elsevier
Context There is controversy regarding the therapeutic role of pelvic lymph node dissection
(PLND) in patients undergoing radical prostatectomy for prostate cancer (PCa). Objective To …

High-risk prostate cancer—classification and therapy

AJ Chang, KA Autio, M Roach III, HI Scher - Nature reviews Clinical …, 2014 - nature.com
Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease.
However, the current definitions of high-risk prostate cancer include a heterogeneous group …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, J Bellmunt, M Bolla, E Briers… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …

Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer

G Gandaglia, N Fossati, E Zaffuto, M Bandini… - European urology, 2017 - Elsevier
Background Preoperative assessment of the risk of lymph node invasion (LNI) is mandatory
to identify prostate cancer (PCa) patients who should receive an extended pelvic lymph …

Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer

MCF Cysouw, BHE Jansen, T van de Brug… - European journal of …, 2021 - Springer
Purpose Quantitative prostate-specific membrane antigen (PSMA) PET analysis may
provide for non-invasive and objective risk stratification of primary prostate cancer (PCa) …

Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive …

GE Cacciamani, M Maas, N Nassiri, D Ortega… - European urology …, 2021 - Elsevier
Context Pelvic lymph node dissection (PLND) yields the most accurate staging in patients
undergoing radical prostatectomy (RP) for prostate cancer (PCa), although it can be …

Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly …

A Stabile, A Pellegrino, E Mazzone… - European Urology …, 2022 - Elsevier
Context The role of positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA) in the primary staging for patients with prostate …

Pelvic lymph node dissection in prostate cancer

A Briganti, ML Blute, JH Eastham, M Graefen… - European urology, 2009 - Elsevier
CONTEXT: Pelvic lymph node dissection (PLND) is considered the most reliable procedure
for the detection of lymph node metastases in prostate cancer (PCa); however, the …

Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

BHE Jansen, YJL Bodar, GJC Zwezerijnen… - European journal of …, 2021 - Springer
Purpose The detection of lymph-node metastases (N1) with conventional imaging such as
magnetic resonance imaging (MRI) and computed tomography (CT) is inadequate for …

French AFU Cancer Committee Guidelines-Update 2022-2024: prostate cancer-Diagnosis and management of localised disease

G Ploussard, G Fiard, E Barret, L Brureau… - Progrès en Urologie, 2022 - Elsevier
Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …